Dashboard
Manage Tickers

ANRO


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
10/20/2025 18:39:30

Core News & Articles
Baird Maintains Outperform on Alto Neurosc...
10/20/2025 17:55:18

Baird analyst Brian Skorney maintains Alto Neuroscience (NYSE:ANRO) with a Outperform and raises the price target from $10 t...

Core News & Articles
Alto Neuroscience Expects To Initiate A Ph...
10/20/2025 11:14:04

Core News & Articles
Alto Neuroscience Announces $50M Private P...
10/20/2025 11:12:59

– Financing led by Perceptive Advisors with participation from new and existing biotech focused investors –– Alto expects to us...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
10/03/2025 17:06:08

Core News & Articles
Alto Neuroscience Says FDA Grants Fast Tra...
10/03/2025 11:35:19

– ALTO-101, a novel PDE4 inhibitor, has demonstrated pro-cognitive effects in healthy volunteers –– Designation highlights the ...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/02/2025 21:06:15

this-electronic-arts-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-monday
This Electronic Arts Analyst Is No Longer ...
09/29/2025 11:52:38

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

this-vse-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This VSE Analyst Begins Coverage On A Bull...
09/29/2025 11:35:20

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

Core News & Articles
Chardan Capital Initiates Coverage On Alto...
09/29/2025 11:24:50

Chardan Capital analyst Rudy Li initiates coverage on Alto Neuroscience (NYSE: ANRO) with a Buy rating and announces Price T...

Core News & Articles
Alto Neuroscience Reports Replication Stud...
09/09/2025 11:16:01

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO) a clinical-stage biopharmaceutical company focused on the development of n...

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Alto...
08/18/2025 17:11:11

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $10 pr...

Core News & Articles
Alto Neuroscience Q2 EPS $(0.65) Misses $(...
08/13/2025 20:25:37

Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.65) per share which missed the analyst consensus estimate of $(0...

Core News & Articles
Alto Neuroscience Highlights Lancet Psychi...
06/30/2025 12:06:29

–  Compelling PAX-D results guided Alto's acquisition of ALTO-207, designed to induce rapid antidepressant effects while mi...

Core News & Articles
HC Wainwright & Co. Reiterates Buy on Alto...
06/26/2025 16:16:35

HC Wainwright & Co. analyst Patrick Trucchio reiterates Alto Neuroscience (NYSE:ANRO) with a Buy and maintains $10 price...

Core News & Articles
Alto Neuroscience Identifies EEG Biomarker...
06/26/2025 11:37:24

Demonstrated target engagement and response prediction for ALTO-203 by theta/beta ratio, a commonly used EEG index of cortical ...

alto-neuroscience-adds-intriguing-depression-asset-via-over-100-million-deal
Alto Neuroscience Adds 'Intriguing' Depres...
06/03/2025 18:48:29

Alto Neuroscience acquires Chase's treatment-resistant depression drug portfolio for $1.75 million upfront; early data show...

Core News & Articles
Alto Buys Depression and Parkinson's Drug ...
06/03/2025 10:05:31

Alto Neuroscience, Inc. ("Alto") (NYSE:ANRO), a clinical-stage biopharmaceutical company focused on the development of ...

Core News & Articles
Wedbush Reiterates Neutral on Alto Neurosc...
05/15/2025 14:49:04

Wedbush analyst Laura Chico reiterates Alto Neuroscience (NYSE:ANRO) with a Neutral and maintains $4 price target.

Core News & Articles
Alto Neuroscience Q1 EPS $(0.56) Beats $(0...
05/14/2025 20:25:57

Alto Neuroscience (NYSE:ANRO) reported quarterly losses of $(0.56) per share which beat the analyst consensus estimate of $(0.6...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION